). In that case, the fungus was indeed a biofactory in the sense that numerous compounds have been reported from the fungus. What is the situation with another FTCM, Cordyceps? The immediate answer is that the state of the art is considerably less developed (see Table 2 for a list of secondary metabolites). There is a general impression that this fungus is being used in a modern context, before the benefits, and even what is being used, have been determined scientifically. Cordyceps is one of a growing number of FTCM being considered as cures for modern human diseases. Many commercial products are available in the market (e.g. Didanosine from Cordyceps militaris). These nutraceuticals are considered to relieve the “stress for humans of living in technologically developed societies” by stimulating basic and secondary responses of the immune system ( Lakhanpal and Rana, 2005).